MAPK14 and pulmonary arterial hypertension: GJIC was dysregulated and MAPKs were activated (P38, pERK1/2) as an early response to the active PAH (1-MeA), but not to 2-MeA, suggesting a structure-activity relationship underlies the efficacy of responses.